1:12 PM
Jun 05, 2017
 |  BC Extra  |  Financial News

Dova, Aileron seek NASDAQ listings

Oncology play Aileron Therapeutics Inc. (Cambridge, Mass.) and rare disease company Dova Pharmaceuticals Inc. (Durham, N.C.) each proposed IPOs on NASDAQ.

Stapled peptide therapeutic company Aileron filed to raise $69 million in an offering underwritten by BofA Merrill Lynch, Jefferies, William Blair and Canaccord. Its lead program, ALRN-6924, is in a Phase I...

Read the full 259 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >